Monsanto Co. (MON) Stock Rating Reaffirmed by Deutsche Bank AG
Monsanto Co. (NYSE:MON)‘s stock had its “buy” rating reaffirmed by research analysts at Deutsche Bank AG in a report issued on Thursday.
Several other equities research analysts have also recently weighed in on MON. Zacks Investment Research upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research report on Wednesday, June 8th. Piper Jaffray Cos. restated an “overweight” rating and issued a $127.00 price objective (up previously from $95.00) on shares of Monsanto in a research report on Monday, June 13th. Argus restated a “buy” rating and issued a $128.00 price objective (up previously from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Goldman Sachs Group Inc. set a $92.00 price objective on shares of Monsanto and gave the company a “sell” rating in a research report on Monday, June 27th. Finally, Vetr upgraded shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 price objective for the company in a research report on Monday, June 27th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Monsanto has a consensus rating of “Buy” and a consensus target price of $114.67.
Monsanto (NYSE:MON) traded up 0.28% during mid-day trading on Thursday, reaching $103.47. 2,178,357 shares of the company traded hands. The stock’s 50-day moving average price is $104.90 and its 200-day moving average price is $101.32. Monsanto has a one year low of $83.73 and a one year high of $114.26. The firm has a market cap of $45.28 billion, a PE ratio of 45.54 and a beta of 1.19.
Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period last year, the firm posted ($0.19) EPS. Analysts forecast that Monsanto will post $4.46 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is presently 89.26%.
In other news, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the sale, the chief operating officer now owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the sale, the chief executive officer now directly owns 21,583 shares in the company, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by insiders.
Hedge funds have recently made changes to their positions in the company. Mycio Wealth Partners LLC raised its stake in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares in the last quarter. Moody National Bank Trust Division raised its stake in shares of Monsanto by 0.3% in the second quarter. Moody National Bank Trust Division now owns 4,883 shares of the company’s stock worth $505,000 after buying an additional 15 shares in the last quarter. Quadrant Capital Group LLC raised its stake in shares of Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock worth $184,000 after buying an additional 16 shares in the last quarter. Advisor Partners LLC raised its stake in shares of Monsanto by 0.4% in the second quarter. Advisor Partners LLC now owns 6,238 shares of the company’s stock worth $645,000 after buying an additional 23 shares in the last quarter. Finally, Trust Co. of Vermont raised its stake in shares of Monsanto by 0.6% in the second quarter. Trust Co. of Vermont now owns 4,932 shares of the company’s stock worth $510,000 after buying an additional 30 shares in the last quarter. 79.02% of the stock is currently owned by institutional investors and hedge funds.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.